Abstract | BACKGROUND AND AIMS: METHODS: This study included 12 patients with obscure GI bleeding (6 male; mean age 62 years) with 39 small-bowel hemangiomas; patients were treated with PDI by using double-balloon endoscopy (DBE). EUS with DBE was performed before PDI. The lesions were divided into 2 groups according to tumor size: Group A (size <10 mm; 20 lesions) and group B (size ≥10 mm; 19 lesions). The outcomes of PDI treatment for small-bowel hemangioma were evaluated between the 2 groups. Additionally, in order to standardize the amount of PDI injected, the total amount of polidocanol according to lesion size was calculated. RESULTS: There was no difference in the location of lesions and treatment times between the 2 groups. Group B had a significantly higher injection time per lesion (P < .05) and amount of polidocanol per lesion than group A (P < .01). Rebleeding occurred in only 1 case (8%). There were no adverse events related to PDI. The contribution ratio between the lesion size and amount of polidocanol showed a correlation (r = 0.77). The optimal amount of polidocanol for small-bowel hemangioma was determined to be 0.2 mL/mm. CONCLUSIONS: PDI is an easy, safe, and effective method to treat small-bowel hemangiomas.
|
Authors | Atsushi Igawa, Shiro Oka, Shinji Tanaka, Sayoko Kunihara, Makoto Nakano, Kazuaki Chayama |
Journal | Gastrointestinal endoscopy
(Gastrointest Endosc)
Vol. 84
Issue 1
Pg. 163-7
(Jul 2016)
ISSN: 1097-6779 [Electronic] United States |
PMID | 26907744
(Publication Type: Journal Article)
|
Copyright | Copyright © 2016 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Sclerosing Solutions
- Polidocanol
- Polyethylene Glycols
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Double-Balloon Enteroscopy
(methods)
- Female
- Gastrointestinal Hemorrhage
(etiology, therapy)
- Hemangioma
(complications, therapy)
- Humans
- Ileal Neoplasms
(complications, therapy)
- Injections, Intralesional
- Jejunal Neoplasms
(complications, therapy)
- Male
- Middle Aged
- Polidocanol
- Polyethylene Glycols
(therapeutic use)
- Retrospective Studies
- Sclerosing Solutions
(therapeutic use)
- Young Adult
|